Clinical Research Directory
Browse clinical research sites, groups, and studies.
Probiotics in Mild Alzheimer's Disease
Sponsor: University of Nicosia
Summary
The main objective is to investigate whether administration of probiotics to patients with mild Alzheimer's Disease (AD) reduces neuroinflammation, improves cognitive function and modifies neurophysiological measures, compared to a patient group that receives placebo (no active probiotics).
Official title: Effect of Probiotics on Cognitive Functioning of Patients With Mild Alzheimer's Disease
Key Details
Gender
All
Age Range
65 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2022-12-19
Completion Date
2025-12-01
Last Updated
2024-12-05
Healthy Volunteers
No
Interventions
Probiotic Blend Capsule
20 million CFU (Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus helveticus, Bifidobacterium breve)
Locations (1)
The Cyprus Institute of Neurology and Genetics
Nicosia, Cyprus